Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02871934 · ClinicalTrials.gov registry record · NA
Integrating Pharmacogenetics In Clinical Care
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 408
- Enrollment target
NCT02871934: Completed NA study, sponsored by VA Office of Research and Development.
NCT02871934 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 408 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02871934, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 408 participants
- Enrollment target
Study Summary
This study will determine whether using a genetic test (for the SLCO1B1 gene) can help patients and providers choose the right type and dose of cholesterol-lowering statin medications to lower the risk of cardiovascular disease, while minimizing the muscle pain side effects that sometimes occur with statins.
Interventions
- GENETIC SLCO1B1 Genotype
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02871934
The ClinicalTrials.gov registry entry for NCT02871934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SLCO1B1 Genotype is the first listed.
NCT02871934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02871934 about?
NCT02871934 is a clinical study titled "Integrating Pharmacogenetics In Clinical Care". This study will determine whether using a genetic test (for the SLCO1B1 gene) can help patients and providers choose the right type and dose of cholesterol-lowering statin medications to lower the risk of cardiovascular disease, while minimizing the muscle pain side effects that sometimes occur with...
What is the current status of trial NCT02871934?
This trial is currently completed. It is a NA study. The enrollment target is 408 participants. The study started on 2016-08-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02871934?
The interventions under investigation include: SLCO1B1 Genotype (GENETIC).
Who is sponsoring clinical trial NCT02871934?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.